Trial intelligence / Profile preview

Correlation Between Gene Mutation and TCM Syndrome Types in Metastatic Colorectal Cancer

NCT04661046Unknown

Sponsor
Shanghai University of Traditional Chinese Medicine
Start
Nov 2020
Primary completion
Aug 2022
Modality
HMF (Herbal Medicine Formulation)
01

Overview

Trial of bazhengsan in colorectal cancer (CRC), sponsored by Shanghai University of Traditional Chinese Medicine. Primary endpoints: Overall Survival at 2 years and Progression Free Survival at 2 years. Status: unknown.

02

Drugs

bazhengsan
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT04661046.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04661046.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call